Such chronically active BCR signaling can be brought about by mutations that cause amino-acid substitutions in the intracellular domains of Igβ or Igα in case of ABC DLBCL22 or by auto-aggregation of BCRs in case of CLL23–25. This evidence concerns the gene BCR and aneurysmal bone cyst.